Costimulatory signals potently modulate the T cell inhibitory capacity of the therapeutic CD11a antibody Efalizumab. [electronic resource]
Producer: 20110623Description: 199-207 p. digitalISSN:- 1521-7035
- 4-1BB Ligand -- pharmacology
- Abatacept
- Antibodies, Monoclonal -- immunology
- Antibodies, Monoclonal, Humanized
- Antigen Presentation -- immunology
- Antigens, CD -- pharmacology
- B7-1 Antigen -- immunology
- CD11a Antigen -- immunology
- CD28 Antigens -- immunology
- CD3 Complex -- immunology
- CD58 Antigens -- immunology
- Cell Proliferation -- drug effects
- Dendritic Cells -- immunology
- Humans
- Immunoconjugates -- pharmacology
- Immunosuppressive Agents -- pharmacology
- Inducible T-Cell Co-Stimulator Ligand
- Intercellular Adhesion Molecule-1 -- metabolism
- Interferon-gamma -- metabolism
- Interleukin-10 -- metabolism
- Interleukin-2 -- pharmacology
- Interleukin-4 -- metabolism
- Leukocytes, Mononuclear -- drug effects
- Lymphocyte Activation -- drug effects
- Lymphocyte Function-Associated Antigen-1 -- metabolism
- Protein Binding -- drug effects
- Psoriasis -- drug therapy
- T-Lymphocytes -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.